Last Notice: Registration for Virtual Dialogue: This Coming Tuesday, September 14 at 7:30PM EST
Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM – 9:00PM (Eastern Standard Time / New York)
This Event is Free to All that Register
Join Us for This Very Informative Event
The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing information to help Chondrosarcoma patients make informed decisions to take charge of their care.
The Virtual Dialogue is scheduled for Tuesday, September 14 at 7:30pm (Eastern Standard Time / New York). Registration for the Virtual Dialogue is still open but we are excited to share that as of today, we have 91 registrations from 16 different countries including, US, UK, Belgium, Ireland , Italy, Australia, Spain, Brazil, Israel, India and the Philippines and in addition to CS Warriors and their families, we have Pathologists, Oncologists, Oncology Radiologists, Clinical Researchers and Sarcoma Specialists from 19 institutions. We are fortunate to be bringing together a large diverse group consisting of CS patients and family, oncology experts from all over the world.
Mike Snyder, is a broadcast engineer for PBS in Albuquerque, N.M. and a Chondrosarcoma survivor since 1996. Mike is the author of the book entitled: No Treatment Options Left: Fighting and Surviving Inoperable Cancer. Mike will address navigating through the healthcare maze, when to get a second opinion and coping with pain and stress.
Christian Meyer, M.D., Ph.D. is the Assistant Professor and lead medical oncologist for adult sarcoma patients at Johns Hopkins University in Baltimore, Md. He will address the treatment and care currently available to treat Chondrosarcoma, the type of surveillance needed and how frequently it should be done, as well as what new techniques and treatments are on the horizon.
Dexter Jin, Ph.D. is the senior scientist on the Cancer Genomics Research team at Foundation Medicine in Cambridge, MA. He works with FMI’s database of over 400,000 patient profiles for biomarker development to better understand the genomics of rare cancers. He will discuss of the benefits of genetic sequencing and how biomarkers can assist in the care and outcome of treating Chondrosarcoma.
James W. Snider, M.D. is an Associate Professor, Radiation Oncologist and Associate Medical Director at the University of Alabama at Birmingham Proton International Centre. He will address when to treat Chondrosarcoma with proton and radiation treatments, and what innovative care is on the horizon.
David Bowles, Ph.D. has a doctorate in organizational psychology and is the author of two business books on employee morale and work culture. In 2017, David was diagnosed with pelvic chondrosarcoma. After refusing surgery he completed proton radiation and started taking the IDH1 inhibitor Tibsovo to deal with metastatic disease. David will address coping with pain, stress, anxiety, how to get the information to make informed decisions and tips for taking charge of your care.